First procedure in Asia-Pacific performed with the Medtronic Hugo ™ robot-assisted surgery system

Robotic prostatectomy took place at Apollo Hospitals, Greams Road, Chennai, India

DUBLIN and CHENNAI from India, September 27, 2021 / PRNewswire / – Medtronic plc (NYSE: MDT) and Apollo Hospitals Group today announced the first clinical procedure in Asia Pacific with the Hugo â„¢ Robot Assisted Surgery (RAS) system. Robotic prostatectomy was performed on September 17 by Dr N Ragavan, Consulting Urologist, Uro-Oncologist and Robotic Surgeon, at Apollo Hospitals, Greams Road, Chennai, India.

“Here in India, nearly 70% of surgeries are performed in open surgery1 – we are confident that the Hugo RAS system will allow us to change this statistic and bring the benefits of minimally invasive surgery to more patients than ever before ”, said Dr Ragavan. “I am incredibly proud to usher in this new era of opportunity for our hospital and the patients we serve with the region’s first-ever clinical procedure with the Hugo RAS System.”

As a form of minimally invasive surgery, robot-assisted surgery offers the potential for fewer complications, shorter hospital stays, faster return to normal activities, and smaller scarring.2-4, †

“Today, we are taking another exciting step to bring the benefits of minimally invasive surgery to more people in more places,” said Megan Rosengarten, president of the surgical robotics business, which is part of Medtronic’s medical surgery portfolio. “This is possible thanks to a vision shared with the Apollo Hospitals, the many surgeons and hospital leaders who have partnered with us on this journey, and our team dedicated to surgical robotics in India and around the world. “

The Hugo RAS System – Medtronic’s solution to historical cost and usability barriers that have kept surgical robotics out of reach for many hospitals – is a multi-quadrant modular platform designed for a wide range of tissue procedures soft. It combines wrist instruments, 3D visualization and Touch Surgery â„¢ Enterprise, a cloud-based surgical video capture and management solution, with dedicated support teams specializing in patient optimization, service and training. robotics programs. Earlier this year, Medtronic announced that the first urologic and gynecologic procedures with the Hugo RAS System took place in Latin America. These procedures marked the start of the Hugo RAS System Patient Registry, which collects clinical data from these systems as well as the system placed in India to support regulatory submissions around the world.

“With the availability of the Hugo RAS system in India, we know the future of surgery is here, ”said Madan Krishnan, Vice President and General Manager, India Medtronic Pvt Ltd. “Medtronic creates robotic-assisted surgery solutions that are optimized for the needs of clinicians today and that can be upgraded as technology evolves and use expands in the years to come. grateful for the opportunity to collaborate with Apollo Hospitals on this exciting milestone and we look forward to collaborating to advance access to the latest therapies for patients. “

“As the region’s leading healthcare provider, we are committed to bringing the very latest medical technologies to our patients,” said Dr. Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group. “The addition of the Hugo RAS system to our robotic surgery program – and our place in history as the first hospital in Asia Pacific to use this new technology – reinforces that dedication and pride we at Apollo Hospitals have as a premier destination for minimally invasive surgery. This technology will complement the excellent clinical expertise our physicians have acquired over the years and is designed to help us improve patient care. “

“We are committed to providing the most advanced and innovative care possible to our patients and are proud to partner with a company that shares our values ​​and vision,” said Ms. Preetha Reddy, Executive Vice President, Apollo Hospitals Group. “There is an urgent need to improve treatment options for surgeries by leveraging technology. Today, robotic technology has come a long way, helping to perform some of the most complicated surgeries with precision, and Apollo has always been at the forefront in bringing the most advanced technology to India. “

The Medtronic Hugo RAS system is commercially available in certain regions. The regulatory requirements of each country and region will determine the approval, authorization or availability in the market. The Hugo RAS system is awaiting CE marking for the EU. In the United States, the Hugo RAS system is an experimental device that is not for sale. Touch Surgery Enterprise is not intended to direct surgery, or to aid in the diagnosis or treatment of any disease or condition.

For more information visit

About Apollo Hospitals
Apollo Hospitals were established in 1983 by Dr Prathap C Reddy, recognized as the architect of modern healthcare in India. As the nation’s premier corporate hospital, Apollo Hospitals is credited with pioneering the private healthcare revolution in the country. Apollo Hospitals emerged as asia leading provider of integrated healthcare services and has a strong presence in the healthcare ecosystem, including hospitals, pharmacies, primary care and diagnostic clinics, and several retail healthcare models. Since its inception, Apollo Hospitals have been honored by the trust of more than 150 million people from 140 countries. At the heart of Apollo’s patient-centered culture is TLC (Tender Loving Care), the magic that inspires hope in its patients. For more details, log in:

About Medtronic
Medtronic plc (, headquartered at Dublin, Ireland, is one of the world’s largest medical technology, services and solutions companies, which relieves pain, restores health and extends the lives of millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on working with stakeholders around the world to advance healthcare, together.

Any forward-looking statement is subject to risks and uncertainties such as those described in Medtronic’s periodic reports filed with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Compared to open surgery.
1. Based on internal estimates and Medtronic report, FY20 market model: procedural volume data.
2. Fitch K, Engel T, Bochner A. Cost differences between open and minimally invasive surgery. Treatment protocol. 2015 Sep; 24 (9): 40-8.
3. Tiwari MM, Reynoso JF, High R, Tsang AW, Oleynikov D. Safety, efficiency and cost-effectiveness of common laparoscopic procedures. Surg Endosc. 2011; 25 (4): 1127-1135.
4. Roumm AR, Pizzi L, Goldfarb NI, Cohn H. Minimally invasive: minimally reimbursed? A review of six laparoscopic surgeries. Surg innovation. 2005; 12 (3): 261-287.


Gary Jeanfaivre

Ryan weispfenning

Public relations

Investor Relations

Medtronic plc

Medtronic plc

+ 1-203-833-2104

+ 1-763-505-4626

Masooma Pathre

Saurabh Bose

Public relations

Brand and Marcomm

Medtronic India

Apollo Hospitals

+91 9819744665

+91 7275798384

Medtronic plc (PRNewsfoto / Medtronic plc)



View original content to download multimedia:

SOURCE Medtronic plc

Previous World class for national education | Mirage News
Next Former toy store now houses Salem's latest career education program

No Comment

Leave a reply

Your email address will not be published.